FREE TREATMENT REPORT

See ratings and reviews when you sign up for an account.

Clinical Testing of a Decision Support System for Tobacco Use Treatment

This study is currently Recruiting

March 2011 By National Cancer Institute (NCI)

First Recieved on March 18, 2009

Last Updated on March 2, 2011

Sponsor: University of Vermont
Collaborators: National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
Identifier: NCT00865553

Purpose

RATIONALE: A computer-assisted stop-smoking program may help doctors counsel patients who smoke and may help increase the number of patients who stop smoking. PURPOSE: This phase II trial is studying how well a computer-assisted stop-smoking program works in helping doctors counsel patients who smoke cigarettes.

Study Type: Interventional
Study Design: Primary Purpose: Health Services Research

Eligibility

Ages Eligible for Study:18 Years
Genders Eligible for Study:Both
Accepts Healthy Volunteers:No
Criteria

DISEASE CHARACTERISTICS: - Current smoker, defined as self-reported smoking most days or every day (patient) - Seeks care at a participating Fletcher Allen Health Care primary care clinic (patient) PATIENT CHARACTERISTICS: - Not specified PRIOR CONCURRENT THERAPY: - Not specified

Investigators

  • Investigator: Theodore W. Marcy, MD, MPH - Principal Investigator - University of Vermont

Locations

  • Vermont Cancer Center at University of Vermont

    Burlington, Vermont 05405-0110 United States

Conditions related to this trial:

advertisement
V2012.311.925.327
Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.